Adenovirus-mediated wild-type p53 overexpression inhibits endothelial cell differentiation in vitro and angiogenesis in vivo

被引:45
作者
Riccioni, T
Cirielli, C
Wang, X
Passaniti, A
Capogrossi, MC
机构
[1] IRCCS, Lab Patol Vasc, Ist Dermatopat Immacolata, I-00167 Rome, Italy
[2] NIA, Gene Therapy Unit, Cardiovasc Sci Lab, NIH, Baltimore, MD 21224 USA
[3] NIA, Biol Chem Lab, Gerontol Res Ctr, NIH, Baltimore, MD 21224 USA
关键词
gene therapy; adenovirus; angiogenesis; p53; endothelium;
D O I
10.1038/sj.gt.3300681
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Gene therapy with the tumor suppressor gene p53 induces cancer cell apoptosis in vitro and in vivo and inhibits tumor growth in nude mice. We hypothesized that in addition to cancer cell apoptosis, a replication-deficient adenovirus vector which carries the cDNA for human wild-type p53 (AdCMV.p53) may also modulate endothelial cell function and inhibit angiogenesis. Human umbilical vein endothelial cells (HUVEC) were infected at different multiplicities of infection (MOI) with either AdCMV.p53, the control vector null or were not infected. Western blot analysis showed p53 overexpression up to 7 days after infection with AdCMV.p53. HUVEC proliferation was either not affected (20 and 50 MOI) or inhibited to comparable levels (100 MOI; P<0.05) in AdCMV.p53- and AdCMV.null-infected versus uninfected cells. HUVEC different into capillary-like structures on reconstituted basement membrane proteins (Matrigel) was assessed 48 h after infection (100 MOI).After 18 h on Matrigel the capillary-like network formed by AdCMV.p53-infected HUVEC was less extensive th-an that formed by both AdCMV.null-infected and uninfected control cells (P<0.05 versus either control). in contrast, conditioned medium from AdCMV.p53-infected HUVEC did not modulate endothelial cell differentiation on Matrigel. The effect of AdCMV.p53 on angiogenesis in vivo was assessed by injecting this vector subcutaneously in mice; 3 days later Matrigel containing basic fibroblast growth factor (bFGF) was injected at the same site. Ir? other experiments AdCMV.p53 was injected simultaneously with an Ad vector coding for vascular endothelial growth factor (AdCMV.VEGF(165)) into the rat perirenal fat tissue. AdCMV.p53 significantly inhibited neovascularization induced by bFGF within the Matrigel plugs (P<0.05) or by AdCMV.VEGF(165) in the fat tissue (P <0.05). Thus, the anti-angiogenic effect of Ad-mediated wild-type p53 overexpression may contribute to the ability of this viral vector to inhibit tumor growth.
引用
收藏
页码:747 / 754
页数:8
相关论文
共 41 条
[1]  
ALBELDA SM, 1990, CANCER RES, V50, P6757
[2]   ADENOVIRUS-MEDIATED P53 GENE DELIVERY INHIBITS 9L GLIOMA GROWTH IN RATS [J].
BADIE, B ;
DRAZAN, KE ;
KRAMAR, MH ;
SHAKED, A ;
BLACK, KL .
NEUROLOGICAL RESEARCH, 1995, 17 (03) :209-216
[3]   INVOLVEMENT OF INTEGRINS IN CELL-SURVIVAL [J].
BATES, RC ;
LINCZ, LF ;
BURNS, GF .
CANCER AND METASTASIS REVIEWS, 1995, 14 (03) :191-203
[4]   REQUIREMENT OF VASCULAR INTEGRIN ALPHA(V)BETA(3) FOR ANGIOGENESIS [J].
BROOKS, PC ;
CLARK, RAF ;
CHERESH, DA .
SCIENCE, 1994, 264 (5158) :569-571
[5]   ADENOVIRUS-MEDIATED GENE-TRANSFER OF WILD-TYPE P53 RESULTS IN MELANOMA CELL APOPTOSIS IN-VITRO AND IN-VIVO [J].
CIRIELLI, C ;
RICCIONI, T ;
YANG, CL ;
PILI, R ;
GLOE, T ;
CHANG, J ;
INYAKU, K ;
PASSANITI, A ;
CAPOGROSSI, MC .
INTERNATIONAL JOURNAL OF CANCER, 1995, 63 (05) :673-679
[6]  
CLAYMAN GL, 1995, CANCER RES, V55, P1
[7]   CONTROL OF ANGIOGENESIS IN FIBROBLASTS BY P53 REGULATION OF THROMBOSPONDIN-1 [J].
DAMERON, KM ;
VOLPERT, OV ;
TAINSKY, MA ;
BOUCK, N .
SCIENCE, 1994, 265 (5178) :1582-1584
[8]  
DRAZAN KE, 1994, SURGERY, V116, P197
[9]   CONTROLLING THE VASCULATURE - ANGIOGENESIS, ANTI-ANGIOGENESIS AND VASCULAR TARGETING OF GENE-THERAPY [J].
FAN, TPD ;
JAGGAR, R ;
BICKNELL, R .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1995, 16 (02) :57-66
[10]  
FOLKMAN J, 1992, J BIOL CHEM, V267, P10931